Luye Pharma Group Ltd

Luye Pharma Group Ltd., with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. Its products include Lipusu for ovarian cancer, CMNa for cancer radiotherapy, Boyounuo for various cancers, and Xuezhikang for hypercholesterolaemia. It also offers Maitongna for cerebral edema and venous reflux disorders, Beixi for Type 2 diabetes, and Seroquel, Seroquel XR, Erzofri, and various transdermal patches. Additional products include Rykindo for schizophrenia, Boyoubei for osteoporosis, and Boyouping for glycemic control. The company was founded in 1994 and is headquartered in Yantai, the People's Republic of China.